arrow
S

Samantha M. Loi

university of melbourne
H指数:26
被引数:2,803

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

澳大利亚和新西兰精神分裂症初始躯体健康评估:2026年建议

2026-04-260
OA
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic

血浆p-tau217、NfL、GFAP在阿尔茨海默病、额颞叶痴呆和精神障碍中的诊断性能及生物标志物特征,在一项前瞻性、非选择性的神经精神科记忆门诊研究。

2025-09-300
OAAI
The road to young-onset dementia diagnosis: Findings from the Joint Solutions Project

青年期痴呆症诊断之路:联合解决方案项目的发现

2025-08-120
OAAI
Multimorbidity in dementia: Current perspectives and future challenges

痴呆中的多病共存:当前观点与未来挑战

2025-08-040
OAAI
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease

淡漠和与血浆神经丝蛋白轻链升高相关但与p-tau181无关的阿尔茨海默病情感症状

2025-07-290
OAAI
Lived experience perspectives about gaps and barriers in services for those living with, and those providing care, for people with young-onset dementia in Australia: Findings from the Joint Solutions Project

关于澳大利亚年轻发病痴呆症患者及其护理人员在接受和提供照护服务中存在的差距和障碍的亲历者观点:联合解决方案项目的研究发现

2025-06-240
PRE
Resistance and resilience to Alzheimer's disease in Down syndrome

唐氏综合征中对抗阿尔茨海默病的抵抗力和恢复力

2025-04-280
OAAI
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research

额颞叶痴呆的生物医学研究差距: 呼吁多样性和差异集中研究

2024-11-130
OAAI
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting

在临床环境中,血浆和CSF神经丝轻链可区分神经退行性病变和原发性精神病

2024-10-062
OA
Promoting Independence Through Quality Dementia Care at Home (PITCH): An Australian Stepped-Wedge Cluster Randomised Controlled Trial Evaluating a Dementia Training Program for Home Care Workers

通过优质的居家痴呆症护理促进独立性 (PITCH): 一项澳大利亚阶梯式楔形集群随机对照试验,评估了针对家庭护理人员的痴呆症培训计划

2024-09-050
OAAI
Efficacy and safety of ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in younger patients (pts) with HR+/HER2-early breast cancer (EBC) in NATALEE

瑞博西利(RIB)联合非甾体类芳香化酶抑制剂(NSAI)在年轻激素受体阳性/人表皮生长因子受体2阴性早期乳腺癌(EBC)患者(pts)中的疗效与安全性研究(NATALEE研究)。

2024-09-011
PRE